ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BOOKANAKERE NIRANJAN M.D., M.P.H.

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,790Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 43

$559K Total Retail Price of All Prescriptions

Rank: 9 out of 43

452 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

23% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 16%.

Schedule Three
Controlled Substances

13% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 10,346 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
WARFARIN SODIUM 667 657 1 2
FUROSEMIDE 552 541 2 4
LEVOTHYROXINE SODIUM 428 417 3 1
SIMVASTATIN 354 328 4 6
METOPROLOL TARTRATE 320 309 5 8
CITALOPRAM HBR 249 233 6 10
LISINOPRIL 242 221 7 3
NAMENDA 241 241 8 24
AMLODIPINE BESYLATE 237 234 9 9
DONEPEZIL HCL 224 224 10 13
GABAPENTIN 211 211 11 11
HYDROCODONE-ACETAMINOPHEN 208 200 S3 12 5
OMEPRAZOLE 207 207 13 7
POTASSIUM CHLORIDE 192 192 14 14
METOPROLOL SUCCINATE 166 166 15 23
SPIRONOLACTONE 162 162 16 59
LIDODERM 131 131 17 48
CYMBALTA 125 113 18 32
SERTRALINE HCL 119 112 19 25
POLYETHYLENE GLYCOL 3350 116 114 20 42
ESCITALOPRAM OXALATE 111 110 21 46
ALENDRONATE SODIUM 109 109 22 18
TRAMADOL HCL 108 108 23 20
ADVAIR DISKUS 106 104 24 49
IPRATROPIUM-ALBUTEROL 100 100 25 53
TAMSULOSIN HCL 92 85 26 22
DIGOXIN 87 87 27 67
METFORMIN HCL 84 60 28 12
OXYCODONE HCL 84 70 S2 28 15
ENOXAPARIN SODIUM 82 82 30 129
OXYCONTIN 81 58 S2 31 45
VANCOMYCIN HCL 75 75 32 125
QUETIAPINE FUMARATE 75 67 32 26
SPIRIVA 73 73 34 54
ATENOLOL 72 72 35 16
CARVEDILOL 72 72 35 40
ATORVASTATIN CALCIUM 71 71 37 28
PREDNISONE 70 69 38 43
LANTUS 70 69 38 30
CIPROFLOXACIN HCL 69 62 40 64
RAMIPRIL 63 63 41 95
RANITIDINE HCL 63 63 41 39
OXYCODONE-ACETAMINOPHEN 62 51 S2 43 17
LEVOFLOXACIN 61 60 44 65
JANUVIA 56 56 45 104
PANTOPRAZOLE SODIUM 55 55 46 61
FLUTICASONE PROPIONATE 53 49 47 60
LATANOPROST 52 52 48 115
HYDRALAZINE HCL 50 50 49 85
VENLAFAXINE HCL ER 50 50 49 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.